Company / Free Cash Flow
Marker Therapeutics, Inc. Free Cash Flow History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$18.7M
FY2019
5-year range
-$18.7M / -$8.4M
FY2018-FY2019
Trend
-121.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$19M in FY2019.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow decreased 121.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2019 | -$18.7M | -121.1% |
| FY2018 | -$8.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026